A Study to Evaluate the Effects of Tedizolid Phosphate on the Pharmacokinetics and Safety of Midazolam and Rosuvastatin (MK-1986-004)

• Status: Completed
• Trial end date: 2015-08-01

Summary

The purpose of this study is to assess the effect of steady-state tedizolid phosphate on the single-dose pharmacokinetics of midazolam and rosuvastatin in healthy, adult participants.

• Phase: Phase 1

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Midazolam; Oxazolidinones; Rosuvastatin Calcium; Tedizolid; Tedizolid phosphate; Torezolid; Torezolid phosphate